Amolyt Pharma
Amolyt Pharma is a therapeutic Peptides founded in 2015.
2
Funding Rounds
$220.0m
Money raised
Funding
Funding series
Funding Series Analysis
The company Amolyt Pharma has raised a total of $220m in funding over 2 rounds.
Key Insights:
- Amolyt Pharma January 2023 Series C Funding Round: $140m
- Amolyt Pharma Series B round, September 2021: $80m
Amolyt Pharma January 2023 Series C Funding Round
$140m
Amolyt Pharma Series B round, September 2021
$80m
Industries
Amolyt Pharma is active in the following industries: